Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Decru

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Medical Virology|November 24, 2020
No SARS-CoV-2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in BelgiumStefanie Desmet, Esra Ekinci, Ine Wouters, et al.
Clinical Chemistry and Laboratory Medicine|November 29, 2023
Pseudohyperglycemia due to glucometer interference in galactosemiaBram Decru, Hilde Blanckaert, Gunnar Naulaers, et al.
Molecular Genetics and Metabolism|January 11, 2025
Mitochondrial HMG-CoA synthase deficiencyBram Decru, Marine Lys, Kobe Truijens, et al.
Clinical Chemistry and Laboratory Medicine|July 7, 2020
Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2Bram Decru, Jan Van Elslande, Matthias Weemaes, et al.
Molecular Metabolism|June 30, 2022
Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunctionIsabelle Adant, Matthew Bird, Bram Decru, et al.
Frontiers in Immunology|December 12, 2022
Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Frontiers in Immunology|July 5, 2022
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare WorkersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2020
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAsJan Van Elslande, Bram Decru, Stijn Jonckheere, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Medical Virology|November 24, 2020
No SARS-CoV-2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in BelgiumStefanie Desmet, Esra Ekinci, Ine Wouters, et al.
Clinical Chemistry and Laboratory Medicine|November 29, 2023
Pseudohyperglycemia due to glucometer interference in galactosemiaBram Decru, Hilde Blanckaert, Gunnar Naulaers, et al.
Molecular Genetics and Metabolism|January 11, 2025
Mitochondrial HMG-CoA synthase deficiencyBram Decru, Marine Lys, Kobe Truijens, et al.
Clinical Chemistry and Laboratory Medicine|July 7, 2020
Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2Bram Decru, Jan Van Elslande, Matthias Weemaes, et al.
Molecular Metabolism|June 30, 2022
Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunctionIsabelle Adant, Matthew Bird, Bram Decru, et al.
Frontiers in Immunology|December 12, 2022
Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Frontiers in Immunology|July 5, 2022
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare WorkersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2020
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAsJan Van Elslande, Bram Decru, Stijn Jonckheere, et al.
Pageof 1